Corrigendum to "Deconstructing estradiol: Removal of B-ring generates compounds which are potent and subtype-selective estrogen receptor agonists" [Bioorg. Med. Chem. Lett. 19 (2009) 1250-1253] (DOI:10.1016/j.bmcl.2008.12.080);Deconstructing estradiol: Removal of B-ring generates compounds which are potent and subtype-selective estrogen receptor agonists

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 4, 2009, Pages 1250-1253

  Asim, Mohammud ^a   El Salfiti, Mohamed ^a   Qian, Yiming ^a   Choueiri, Christine ^a   Salari, Samira ^a   Cheng, James ^a   Shadnia, Hooman ^b   Bal, Manpartap ^b   Christine Pratt, M A ^a   Carlson, Kathryn E ^c   Katzenellenbogen, John A ^c   Wright, James S ^b   Durst, Tony ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CARLETON UNIVERSITY   (Canada)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Estradiol; Estrogen receptor selectivity; Hormone replacement therapy; Quinone metabolites; Synthetic hormones

Indexed keywords

ESTRADIOL; ESTRADIOL DERIVATIVE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; PRINABEREL; UNCLASSIFIED DRUG; WAY 202196;

ARTICLE; DRUG RECEPTOR BINDING; MOLECULAR DOCKING; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

EID: 59649129757     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.12.117     Document Type: Erratum

References (19)

1. Palmieri C., Cheng G.J., Saji S., Zelada-Hedman M., Warri A., Weihua Z., Van Noorden S., Wahlstrom T., Coombes R.C., Warner M., and Gustafsson J.-A. Endocr. Relat. Cancer 9 (2002) 1
2. Jordan V.C. J. Med. Chem. 46 (2003) 1081
3. Dahlman-Wright K., Cavailles V., Fuqua S.K., Jordan V.C., Katzenellenbogen J.A., Korach K.S., Maggi A., Muramatsu M., Parker M.G., and Gustafsson J.-A. Pharmacol. Rev. 58 (2006) 773
4. MacGregor J.I., and Jordan V.C. Pharmacol. Rev. 50 (1998) 151
5. Crabtree J.S., Zhang X., Peano B.J., Zhang Z., Winneker R.C., and Harris H.A. J. Steroid Biochem. Mol. Biol. 101 (2006) 11
6. Harris H.A., Albert L.M., Leathurby Y., Malamas M.S., Mewshaw R.E., Miller C.P., Kharode Y.P., Marzolf J., Komm B.S., Winneker R.C., et al. Endocrinology 144 (2003) 4241
7. Cvoro A., Tatomer D., Tee M.K., Zogovic T., Harris H.A., and Leitman D.C. J. Immunol. 180 (2008) 630
8. Williamson-Hughes P.S., Flickinger B.D., Messina M.J., and Empie M.W. Menopause 5 (2006) 831
9. Martín-Santamaría S., Rodríguez J.J., de Pascual-Teresa S., Gordon S., Bengtsson M., Garrido-Laguna I., Rubio-Viqueira B., López-Casas P.P., Hidalgo M., de Pascual-Teresa B., and Ramos A. Org. Biomol. Chem. 6 (2008) 3486
10. Wilkening R.R., Ratcliffe R.W., Tynebor E.C., Wildonger K.J., Fried A.K., Hammond M.L., Mosley R.T., Fitzgerald P.M.D., Sharma N., McKeever B.M., Nilsson S., Carlquist M., Thorsell A., Locco L., Katz R., Frisch K., Birzin E.T., Wilkinson H.A., Mitra S., Cai S., Hayes E.C., Schaeffer J.M., and Rohrer S.P. Bioorg. Med. Chem. Lett. 13 (2006) 3489
11. Wilkening R.R., Ratcliffe R.W., Fried A.K., Meng D., Sun W., Colwell L., Lambert S., Greenlee M., Nilsson S., Thorsell A., Mojena M., Tudela C., Frisch K., Chan W., Birzin E.T., Rohrer S.P., and Hammond M.L. Bioorg. Med. Chem. Lett. 16 (2006) 3896
12. Shadnia, H.; Wright, J. S., unpublished results.
13. Duckworth H.W., and Coleman J.E. J. Biol. Chem. 245 (1970) 1613
14. Bolton J.L., and Thatcher G.R.J. Chem. Res. Toxicol. 21 (2008) 93
15. Yu L., Liu H., Li W., Zhang F., Luckie C., Van Breemen R.B., Thatcher G.R.J., and Bolton J.L. Chem. Res. Toxicol. 17 (2004) 879
16. Hajos Z.G. J. Org. Chem. 39 (1974) 1615
17. Wichai U., and Woski S.A. Bioorg. Med. Chem. Lett. 8 (1998) 3465
18. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.-K. Endocrinology 138 (1997) 853
19. Roche Diagnostics Corporation, Roche Applied Science, Indianapolis, IN 46250-0414, USA.